Published in Dermatologica on January 01, 1983
Spatial distribution of 8-methoxypsoralen penetration into human skin after systemic or topical administration. Br J Clin Pharmacol (2002) 0.76
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm. J Viral Hepat (2014) 2.23
Expert opinion on the treatment of patients with chronic hepatitis C. J Viral Hepat (2008) 1.85
Historical epidemiology of hepatitis C virus (HCV) in selected countries. J Viral Hepat (2014) 1.68
Strategies to manage hepatitis C virus (HCV) disease burden. J Viral Hepat (2014) 1.67
Microsatellite-based high density linkage map in oil palm (Elaeis guineensis Jacq.). Theor Appl Genet (2005) 1.61
Nevus lipomatosus cutaneous superficialis. An electron microscopic study of four cases. J Cutan Pathol (1980) 1.47
Dynamics of hepatitis B virus quasispecies heterogeneity and virologic response in patients receiving low-to-moderate genetic barrier nucleoside analogs. J Viral Hepat (2012) 1.42
EMLA cream as a topical anesthetic for the repeated mechanical debridement of venous leg ulcers: a double-blind, placebo-controlled study. J Am Acad Dermatol (1999) 1.41
Review article: specifically targeted anti-viral therapy for hepatitis C - a new era in therapy. Aliment Pharmacol Ther (2010) 1.36
Multicenter performance evaluation of a new TaqMan PCR assay for monitoring human immunodeficiency virus RNA load. J Clin Microbiol (2006) 1.29
[Prophylaxis, diagnosis and therapy of hepatitis B virus infection - the German guideline]. Z Gastroenterol (2011) 1.24
New HCV therapies on the horizon. Clin Microbiol Infect (2011) 1.23
Improved COBAS TaqMan hepatitis C virus test (Version 2.0) for use with the High Pure system: enhanced genotype inclusivity and performance characteristics in a multisite study. J Clin Microbiol (2007) 1.22
Development, characterisation, and across-taxa utility of oil palm (Elaeis guineensis Jacq.) microsatellite markers. Genome (2001) 1.19
Review article: predicting response in hepatitis C virus therapy. Aliment Pharmacol Ther (2006) 1.15
Mutations selected in the hepatitis C virus NS3 protease domain during sequential treatment with boceprevir with and without pegylated interferon alfa-2b. J Viral Hepat (2011) 1.03
Hepatic and portal vein flow pattern in correlation with intrahepatic fat deposition and liver histology in patients with chronic hepatitis C. AJR Am J Roentgenol (1998) 1.03
13C-methacetin breath test as liver function test in patients with chronic hepatitis C virus infection. Aliment Pharmacol Ther (2005) 1.02
Apoptotic cytokeratin 18 neoepitopes in serum of patients with chronic hepatitis C. J Viral Hepat (2005) 0.99
Cross-genotype-reactivity of the immunodominant HCV CD8 T-cell epitope NS3-1073. Vaccine (2008) 0.99
Therapeutic response to taxol of six human tumors xenografted into nude mice. Cancer Chemother Pharmacol (1986) 0.96
High-throughput screening for biocatalysts. Curr Opin Biotechnol (2001) 0.96
Mutations in the putative HCV-E2 CD81 binding regions and correlation with cell surface CD81 expression. J Viral Hepat (2004) 0.96
Variation analysis of six HCV viral load assays using low viremic HCV samples in the range of the clinical decision points for HCV protease inhibitors. Med Microbiol Immunol (2014) 0.95
Real-time tissue elastography versus FibroScan for noninvasive assessment of liver fibrosis in chronic liver disease. Ultraschall Med (2009) 0.94
Anaphylactic reaction to ranitidine and dexchlorpheniramine. Eur J Dermatol (2007) 0.94
Novel methods for biocatalyst screening. Curr Opin Chem Biol (2001) 0.93
Acoustic radiation force impulse imaging for non-invasive assessment of liver fibrosis in chronic hepatitis B. J Viral Hepat (2012) 0.93
[Serious blisters with nephritis due to iodides following radiologic exploration]. Lyon Med (1967) 0.92
Effect of ribavirin on virus load and quasispecies distribution in patients infected with hepatitis C virus. J Hepatol (1998) 0.92
Prospective study of bone mineral density and metabolism in patients with chronic hepatitis C during pegylated interferon alpha and ribavirin therapy. J Viral Hepat (2008) 0.92
Roxithromycin in skin and soft tissue infections. J Antimicrob Chemother (1987) 0.91
An enantioselective fluorimetric assay for alcohol dehydrogenases using albumin-catalyzed beta-elimination of umbelliferone. Bioorg Med Chem Lett (1998) 0.91
UV-A1 cytotoxicity and antioxidant defence in keratinocytes and fibroblasts. Eur J Dermatol (1999) 0.90
Phosphofurylalanine, a stable analog of phosphohistidine. Bioorg Med Chem Lett (1999) 0.90
Antibody-catalyzed reversal of chemoselectivity. Proc Natl Acad Sci U S A (1993) 0.89
Induction of hepatitis C virus (HCV)-specific T cells by needle stick injury in the absence of HCV-viraemia. Eur J Clin Invest (2007) 0.89
Zinc status in patients with telogen defluvium. Acta Derm Venereol (1995) 0.88
Pefloxacin in rabbits: protein binding, extravascular diffusion, urinary excretion and bactericidal effect in experimental endocarditis. J Antimicrob Chemother (1984) 0.87
High-dose silibinin rescue treatment for HCV-infected patients showing suboptimal virologic response to standard combination therapy. J Viral Hepat (2011) 0.87
Multicenter randomized comparative double-blind controlled clinical trial of the safety and efficacy of zinc gluconate versus minocycline hydrochloride in the treatment of inflammatory acne vulgaris. Dermatology (2001) 0.86
Low doses of zinc gluconate for inflammatory acne. Acta Derm Venereol (1989) 0.86
Serum microRNA-122 kinetics in patients with chronic hepatitis C virus infection during antiviral therapy. J Viral Hepat (2013) 0.86
Dynamics of hepatitis C virus quasispecies turnover during interferon-alpha treatment. J Viral Hepat (2003) 0.85
Role of ultrasonography in the detection of small adrenal masses. Ultraschall Med (2002) 0.84
[Leg ulcer and Klinefelter syndrome]. J Mal Vasc (1995) 0.84
Protective effect of selenium and zinc on UV-A damage in human skin fibroblasts. Photochem Photobiol (1993) 0.84
Diels-Alder reactions between dienamides and quinones: stereochemistry of the cycloadditions and cytotoxic activity of the adducts. Chem Pharm Bull (Tokyo) (1990) 0.83
[Cutaneous symptoms of thrombocytemia (author's transl)]. Ann Dermatol Venereol (1977) 0.83
Effect of zinc supplementation on resistance of cultured human skin fibroblasts toward oxidant stress. Biol Trace Elem Res (1993) 0.82
13C-methacetin-breath test compared to also noninvasive biochemical blood tests in predicting hepatic fibrosis and cirrhosis in chronic hepatitis C. Dig Liver Dis (2008) 0.82
Impaired health-related quality of life in patients with chronic hepatitis C and persistently normal aminotransferase levels. J Viral Hepat (2006) 0.82
Fluorogenic polypropionate fragments for detecting stereoselective aldolases. Chemistry (2000) 0.82
Impact of ribavirin priming on viral kinetics and treatment response in chronic hepatitis C genotype 1 infection. J Viral Hepat (2013) 0.82
Transcriptional response of MxA, PKR and SOCS3 to interferon-based therapy in HCV genotype 4-infected patients and contribution of p53 to host antiviral response. Intervirology (2011) 0.82
[Endoscopic-retrograde cholangiopancreatography in patients with surgical modification of anatomy]. Z Gastroenterol (2010) 0.82
[Cutaneous argyria: an electron microscopic study of four eases with microanalysis X study of one case (author's transl)]. Ann Dermatol Venereol (1980) 0.82
Antibody catalysis of a reaction otherwise strongly disfavoured in water. Nature (1995) 0.82
In vitro and in vivo antitumoral activity of free, and encapsulated taxol. J Microencapsul (1990) 0.81
Analysis of Usnea fasciata crude extracts with antineoplastic activity. Tokai J Exp Clin Med (1994) 0.81
Peroral cholangioscopy for diagnosis and therapy of biliary tract disease using an ultra-slim gastroscope. Endoscopy (2011) 0.81
Synthesis of furonaphth[1,3]oxazine and furo[1,3]oxazinoquinoline derivatives as precursors for an o-quinonemethide structure and potential antitumor agents. Chem Pharm Bull (Tokyo) (1996) 0.81
Letter: Telaprevir triple therapy in chronic hepatitis C genotype 1 patients receiving haemodialysis. Aliment Pharmacol Ther (2014) 0.81
[Skin manifestations of Hodgkin's disease. Apropos of a study of 94 patients with this disease]. Sem Hop (1973) 0.81
Correlation of amino acid variations within nonstructural 4B protein with initial viral kinetics during interferon-alpha-based therapy in HCV-1b-infected patients. J Viral Hepat (2007) 0.80
[Acquired ichthyosis as a symptom of breast neoplasm]. Bull Soc Fr Dermatol Syphiligr (1972) 0.80
[Treatment of chloasma caused by oral contraceptives by a vitamin B complex. Preliminary note]. Bull Soc Fr Dermatol Syphiligr (1971) 0.80
Effects of fish oil fatty acids on plasma lipids and lipoproteins and oxidant-antioxidant imbalance in healthy subjects. Scand J Clin Lab Invest (1999) 0.80
[Drug-induced cutaneous photosensitivity. Results of a consensus meeting]. Therapie (1989) 0.80
Asymmetric organic synthesis with catalytic antibodies. Acta Chem Scand (1996) 0.80
A novel therapeutic approach to psoriasis with combination calcipotriol ointment and very low-dose cyclosporine: results of a multicenter placebo-controlled study. J Am Acad Dermatol (1994) 0.79
Antitumor activity of patulin and structural analogs. Pharmazie (1992) 0.79
Synthesis and evaluation of aminocyclopentitol inhibitors of beta-glucosidases. Org Lett (2000) 0.79
[Postexposure prevention after occupational exposure to HBV, HCV and HIV]. Unfallchirurg (2004) 0.79
Clinical evaluation of topical isotretinoin in the treatment of actinic keratoses. J Am Acad Dermatol (1994) 0.78
Somatic hypermutation and mRNA expression levels of the BCL-6 gene in patients with hepatitis C virus-associated lymphoproliferative diseases. J Viral Hepat (2007) 0.78
[Treatment of hepatitis C]. Internist (Berl) (2015) 0.78
Penicillamine induced elastosis perforans serpiginosa: an ultrastructural study of two cases. J Cutan Pathol (1982) 0.78
[A new type of accidental chlorine acne in a group]. Bull Soc Fr Dermatol Syphiligr (1968) 0.78
Isoenzyme pattern of enolase in the diagnosis of neuroendocrine bronchopulmonary tumors. Cancer (1987) 0.78
Peri-hepatic lymphadenopathy in primary biliary cirrhosis reflects progression of the disease. Eur J Gastroenterol Hepatol (1999) 0.78
Statistical study of individual variations in sunburn sensitivity in 303 volunteers without photodermatosis. Arch Dermatol Res (1982) 0.78
Does manganese protect cultured human skin fibroblasts against oxidative injury by UVA, dithranol and hydrogen peroxide? Free Radic Res (1995) 0.77
Pivalase catalytic antibodies: towards abzymatic activation of prodrugs. Chemistry (2001) 0.77
Synthesis and in vitro cytotoxic activity of aza- and diazaanthraquinone derivatives. Pharmazie (1994) 0.77
Hepatocellular proliferation in patients with chronic hepatitis C and persistently normal or abnormal aminotransferase levels. J Hepatol (2000) 0.77
Contact urticaria photoinduced by benzophenones. Contact Dermatitis (2003) 0.77
Randomized double-blind multicenter study comparing acitretin-PUVA, etretinate-PUVA and placebo-PUVA in the treatment of severe psoriasis. Dermatologica (1988) 0.77
Thiols and selenium: protective effect on human skin fibroblasts exposed to UVA radiation. J Photochem Photobiol B (1997) 0.77
Self-expandable metal stent for malignant colonic obstruction: outcome in proximal vs. left sided tumor localization. Z Gastroenterol (2013) 0.77